TrialTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2013

High COL4A3 expression correlates with poor prognosis after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Cheng-Ping Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.